714
Views
19
CrossRef citations to date
0
Altmetric
Cell Cycle News & Views

Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155

, &
Page 2172 | Received 14 Jun 2013, Accepted 17 Jun 2013, Published online: 26 Jun 2013

References

  • Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, et al. Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009. Clin Cancer Res 2012; 18:5051 - 60; http://dx.doi.org/10.1158/1078-0432.CCR-12-0604; PMID: 22850569
  • Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, et al. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle 2013; 12; http://dx.doi.org/10.4161/cc.24987; PMID: 23676217
  • Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011; 118:5891 - 900; http://dx.doi.org/10.1182/blood-2011-06-358382; PMID: 21865341
  • Litvinov IV, Jones DA, Sasseville D, Kupper TS. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma. Clin Cancer Res 2010; 16:2106 - 14; http://dx.doi.org/10.1158/1078-0432.CCR-09-2879; PMID: 20233883
  • Abraham RM, Zhang Q, Odum N, Wasik MA. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Cancer Biol Ther 2011; 12:1019 - 22; http://dx.doi.org/10.4161/cbt.12.12.18144; PMID: 22236880
  • Scott LJ. Tofacitinib: a review of its use in adult patients with rheumatoid arthritis. Drugs 2013; 73:857 - 74; http://dx.doi.org/10.1007/s40265-013-0065-8; PMID: 23716132